Interim report January-March 2019: The sixth quarter in row with improved results
· Strong organic growth and improved results · New orthopaedic clinic opened in Stockholm · Vårdsamverkan is investing in tools for analysing and optimising care chains · A postponement of revenue in International has negatively affected the quarter First quarter 2019 · Sales revenues increased to SEK 330.4 million (278.7) · Organic growth increased to 17.4 percent (10.7) · EBITDA increased to SEK 42.2 million (25.8). Excluding impact of IFRS 16, EBITDA increased to SEK 28.8 million (25.8) · EBITDA margin increased to 12.8 percent (9.3). Excluding impact of IFRS 16,